965 results match your criteria: "Centre de Recherche sur l'Inflammation[Affiliation]"

Hepatic Artery Reconstruction Using the Splenic Artery During Pancreatoduodenectomy.

J Am Coll Surg

January 2025

Department of Hepato-biliary-pancreatic Surgery and liver transplantation, APHP, Hôpital Beaujon, DMU DIGEST, Clichy, France.

View Article and Find Full Text PDF

Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.

N Engl J Med

December 2024

From the Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University (J.H., X.L.), and the State Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Institute of Hepatology, Nanfang Hospital (J.H.), Guangzhou, the Department of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University (W.Z.), the Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine (Q.X.), Roche Holding (Q.B., E.C.), Roche Research and Development Center (C.C., Y.H.), and Takeda APAC Biopharmaceutical Research and Development (Q.B.), Shanghai, the Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, First Hospital of Jilin University, Changchun (R.H.), the Center of Infectious Diseases, Laboratory of Infectious and Liver Disease, Institute of Infectious Diseases, West China Hospital, Sichuan University, Chengdu (H.T.), and the Department of Medicine and State Key Laboratory of Liver Research, Queen Mary Hospital, University of Hong Kong, Hong Kong (M.-F.Y.) - all in China; the Division of Infectious Diseases, University Hospital Álvaro Cunqueiro, Galicia Sur Health Research Institute, Servizo Galego de Saúde-Universidade de Vigo, Vigo, Spain (L.E.M.A.); the Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital (S.-S.Y.), and the Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, China Medical University (C.-Y.P.), Taichung, the Department of Internal Medicine, Changhua Christian Hospital, Changhua (W.-W.S.), Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung (W.-L.C.), and National Taiwan University Hospital, Taipei (J.-H.K.) - all in Taiwan; the Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, South Korea (D.J.K.); the HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Center and the Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok (A.A.), and the Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai (A.L.) - both in Thailand; Université de Paris-Cité, Department of Hepatology, Assistance Publique-Hôpitaux de Paris, Hôpital Beaujon, Centre de Recherche sur l'Inflammation, INSERM Unité Mixte de Recherche 1149, Paris (T.A.); F. Hoffmann-La Roche, Basel, Switzerland (F. Canducci, M.T.C., F. Chughlay, K.G., N.G., P.K., R.K., M.T.); Roche Products, Welwyn Garden City (S.D., V.P., B.S., R.U., C.W.), and ID Pharma Consultancy, Yelverton (C.W.) - both in the United Kingdom; Enthera Pharmaceuticals, Milan (F. Canducci); Parexel International, Hyderabad, India (A.P.); and the New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand (E.G.).

Background: Xalnesiran, a small interfering RNA molecule that targets a conserved region of the hepatitis B virus (HBV) genome and silences multiple HBV transcripts, may have efficacy, with or without an immunomodulator, in patients with chronic HBV infection.

Methods: We conducted a phase 2, multicenter, randomized, controlled, adaptive, open-label platform trial that included the evaluation of 48 weeks of treatment with xalnesiran at a dose of 100 mg (group 1), xalnesiran at a dose of 200 mg (group 2), xalnesiran at a dose of 200 mg plus 150 mg of ruzotolimod (group 3), xalnesiran at a dose of 200 mg plus 180 μg of pegylated interferon alfa-2a (group 4), or a nucleoside or nucleotide analogue (NA) alone (group 5) in participants with chronic HBV infection who had virologic suppression with NA therapy. The primary efficacy end point was hepatitis B surface antigen (HBsAg) loss (HBsAg level, <0.

View Article and Find Full Text PDF

MR Elastography Using the Gravitational Transducer.

Sensors (Basel)

December 2024

Research Department of Imaging Physics and Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London WC2R 2LS, UK.

MR elastography is a non-invasive imaging technique that provides quantitative maps of tissue biomechanical properties, i.e., elasticity and viscosity.

View Article and Find Full Text PDF

FAP expression is scarce in epithelial cells.

Gastroenterology

January 2025

Université Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-75018 Paris, France; Department of Pathology, APHP Nord, FHU MOSAIC, Beaujon Hospital, Clichy, France. Electronic address:

View Article and Find Full Text PDF

Lack of fibro-inflammatory response in human mammary adipose tissue in obesity.

Int J Obes (Lond)

December 2024

Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UT3), Toulouse, France.

Background: Understanding how obesity impacts human mammary adipose tissue (MAT) biology is crucial for deciphering its role in mammary epithelium during both physiological and pathophysiological processes, including breast cancer. Hypertrophic mammary adipocytes and Crown-Like Structures are present in MAT of patients with obesity but whether these changes initiate a fibro-inflammatory response at the tissue level remains insufficiently explored.

Objective: We investigated the markers of adipose tissue dysfunction (immune cell infiltration, secretion pattern and fibrosis) in tumor-free MAT of patients with obesity versus patients who are lean.

View Article and Find Full Text PDF

Background: Immune ageing complicates cancer treatment in older individuals. While immunotherapy targeting the PD-1/PD-L1 pathway can reinvigorate T cells, these cells tend to become senescent with age. This study investigates different CD8 T cell subsets usually associated with senescence, in cancer patients over 70 years old who are undergoing anti-PD-1/PD-L1 immunotherapy, and examines the relationship between these senescent cells and prior chemotherapy exposure.

View Article and Find Full Text PDF

The protein tyrosine phosphatase Lyp/PTPN22 drives TNFα-induced priming of superoxide anions production by neutrophils and arthritis.

Free Radic Biol Med

December 2024

INSERM-U1149, CNRS-ERL8252, Université de Paris-Cité, Centre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, DHU FIRE, Faculté de Médecine, Site Xavier Bichat, Paris, France. Electronic address:

Neutrophils are essential for host defense against infections, but they also play a key role in acute and chronic inflammation. The protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene encodes the lymphoid-specific tyrosine phosphatase (Lyp) and a genetic single-nucleotide polymorphism of PTPN22 rs2476601 (R620W) has been associated with several human autoimmune diseases, including rheumatoid arthritis (RA). Here, we investigated the role of Lyp in TNFα-induced priming of neutrophil ROS production and in the development of arthritis using new selective Lyp inhibitors.

View Article and Find Full Text PDF

Scurvy incidence trend among children hospitalised in France, 2015-2023: a population-based interrupted time-series analysis.

Lancet Reg Health Eur

February 2025

Department of General Paediatrics, Paediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Paediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, F-75019, Paris, France.

Background: Scurvy, historically rare in-high income countries, has re-emerged as an indicator of socioeconomic and dietary disparities. Limited data exist on scurvy trends among European children, particularly following socioeconomic changes since the COVID-19 pandemic. This study analysed scurvy incidence trends among French children over a nine-year period, examining potential post-pandemic increases.

View Article and Find Full Text PDF

Microbiological monitoring during antibiotic therapy in patients with ventilated acquired pneumonia: A proof-of-concept.

Anaesth Crit Care Pain Med

December 2024

Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier St Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France; University Paris Cite; Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM UMR-S 942 Mascot, Lariboisière Hospital, Paris, France; INI-CRCT Network, Nancy, France; FHU PROMICE, Paris, France.

View Article and Find Full Text PDF

[The Lyonisation, a "perfume of women"…].

Med Sci (Paris)

December 2024

Centre de recherche sur l'inflammation Inserm U1149, université Paris Cité faculté de médecine, site Bichat, Paris, France.

View Article and Find Full Text PDF

Objectives: This study evaluates the prognostic value of tumor response on CT at 3 months, assessed by Response Evaluation Criteria in Solid Tumors (RECIST), modified RECIST (mRECIST), and Liver Imaging Reporting and Data System Treatment Response Algorithm (LR-TRA) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT).

Materials And Methods: A retrospective analysis was conducted on 102 HCC patients treated with SIRT between 2018 and 2020. RECIST, mRECIST, and LR-TRA were assessed at 3 months post-SIRT.

View Article and Find Full Text PDF

Background: Susac syndrome (SuS) is a rare immune-mediated microangiopathy with potential disabling evolution. We aimed to analyze brain microstructural damage through diffusion tensor imaging (DTI) in SuS and determine its association with poor outcomes.

Method: CarESS study is a prospective multicenter national cohort study of patients with SuS.

View Article and Find Full Text PDF

Knowledge About Human Papillomavirus Among Patients With Immune-Mediated Inflammatory Diseases.

J Rheumatol

December 2024

Karim Sacré, MD, PhD, Département de Médecine Interne, Hôpital Bichat, AP-HP, Université Paris Cité, Paris; INSERM UMR 1149, Centre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, Paris, France.

View Article and Find Full Text PDF

[From incomplete penetrance to variable expressivity or vice versa].

Med Sci (Paris)

November 2024

Centre de recherche sur l'inflammation, Inserm U 1149, université Paris Cité, faculté de médecine Bichat, Paris, France.

View Article and Find Full Text PDF

[Semaphorin-3A signaling decreases the porosity of sinusoidal endothelial cells in steatotic liver diseases].

Med Sci (Paris)

November 2024

Université Paris-Cité, Inserm, Centre de recherche sur l'inflammation, UMR1149, Paris, France - APHP, Hôpital européen George Pompidou, Hôpital Corentin-Celton, Service de gériatrie, Institut CARPEM, Paris, France.

View Article and Find Full Text PDF

[Inhibiting a kinase to stimulate liver regeneration].

Med Sci (Paris)

November 2024

Centre de recherche sur l'inflammation, Inserm U1149, Université Paris Cité, faculté de médecine Bichat, Paris, France.

View Article and Find Full Text PDF

ClustAll: An R package for patient stratification in complex diseases.

PLoS Comput Biol

December 2024

Unit of Translational Bioinformatics, Navarrabiomed-Fundación Miguel Servet, Universidad Publica de Navarra (UPNA), IdiSNA, Pamplona, Spain.

In the era of precision medicine, it is necessary to understand heterogeneity among patients with complex diseases to improve personalized prevention and management strategies. Here, we introduce ClustAll, a Bioconductor package designed for unsupervised patient stratification using clinical data. ClustAll is based on the previously validated methodology ClustAll, a clustering framework that effectively handles intricacies in clinical data, including mixed data types, missing values, and collinearity.

View Article and Find Full Text PDF

Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis.

Nephrol Dial Transplant

December 2024

Department of Nephrology, APHP Hôpital Bichat, 46 Rue Henri Huchard, Paris, INSERM U1149 centre de recherche sur l'inflammation, Université Paris Cité.

Background And Hypothesis: Kidney involvement, along with cardiac disease, is the most frequent manifestation of systemic AL amyloidosis usually resulting in nephrotic-range proteinuria. Rarely, deposits predominantly or exclusively affect the intrarenal arterioles or arteries, these vascular-limited forms following a distinct clinical course, but very little is known about these forms. Our work plan at better characterizing renal vascular limited AL amyloidosis.

View Article and Find Full Text PDF

Association between preoperative uric acid concentration and the occurrence of atrial fibrillation following cardiac surgery: an observational prospective study.

Hellenic J Cardiol

November 2024

Department of Anaesthesiology and Surgical Intensive Care Unit, Groupe Hospitalier Bichat Claude Bernard, DMU PARABOL, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Anesthesiology, Hôpital Louis Mourier, DMU PARABOL, Assistance Publique-Hôpitaux de Paris, Paris, France; Université Paris Cité, Atherothrombotic Disease in Heart and Brain, INSERM UMR 1148, Paris F-75018, France.

Objectives: Uric acid (UA) concentration is associated with increased risk of atrial fibrillation, but few studies have investigated this association after cardiac surgery. This study investigated the statistical association between postoperative atrial fibrillation (POAF) and preoperative UA concentration according to the type of cardiac surgery.

Methods: Consecutive patients undergoing cardiac surgery at a tertiary center from January to May 2019 were eligible.

View Article and Find Full Text PDF

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study.

JHEP Rep

December 2024

Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de InvestigacionsBiomèdiques August Pi iSunyer (IDIBAPS), Departament de Medicina I Ciències de la Salut - University of Barcelona, Barcelona. CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas). Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Rare Liver), Spain.

Background & Aims: Patients with vascular liver diseases (VLD) are at higher risk of both severe courses of COVID-19 disease and thromboembolic events. The impact of SARS-CoV-2 vaccination in patients with VLD has not been described and represents the aim of our study.

Methods: International, multicenter, prospective observational study in patients with VLD analyzing the incidence of COVID-19 infection after vaccination, severity of side effects, occurrence of thromboembolic events and hepatic decompensation.

View Article and Find Full Text PDF

[Hepatocellular carcinoma: Histological and molecular classifications].

Ann Pathol

November 2024

Université Paris Cité, Paris, France; Département de pathologie, FHU MOSAIC, SIRIC InSitu, hôpital Beaujon, AP-HP. Nord, Clichy, France; Centre de recherche sur l'inflammation, Inserm, UMR 1149, Paris, France.

Article Synopsis
  • Hepatocellular carcinoma (HCC) is the most common type of liver cancer and has a poor prognosis, contributing significantly to cancer-related deaths globally.
  • The tumor exhibits both morphological and molecular diversity, with the World Health Organization identifying eight subtypes based on histological characteristics, including steatohepatitic and macrotrabecular massive (MTM), some of which are linked to worse survival rates.
  • Genomic analysis shows common mutations like TERT, as well as later mutations in TP53 and CTNNB1, with TP53 mutations correlating to poorer outcomes, emphasizing the need for detailed subtype classification for better prognosis assessments.
View Article and Find Full Text PDF